Nephrology Flashcards
What is the average physiologic protein excretion in adults?
80mg/day (16-32mg albumin)
What is a pathologic amount of protein excretion?
150mg or more
Microalbuminuria
30-300mg/day
Macroalbuminuria
> 300 mg/day
Nephrotic range of protein
> 3-3.5g
Causes of Proteinuria
Glomerular disease (most common-altered permeability)
Overflow (oveproduction of small proteins)
Tubular (diminished reabsorptive capacity)
Glomerular Disease
Nephritic or nephrotic syndromes
Results in hypoalbuminemia due to loss of protein
Biopsy is gold standard of diagnosis
Nephritic Syndrome
Inflammatory process with associated immunologic response leading to renal glomeruli damage
Nephritic Syndrome Clinical Presentation
Periorbital edema, swollen lips, puffy pale face, “Coca Cola” urine (RBC casts), hypertension, occasional WBCs, proteinuria (but <3.5g/day)
Rapidly Progressing Glomerulonephritis (RPGN)
Severe injury to glomerular capillary wall, GBM and bowman’s capsule; progresses to renal failure in weeks-months
Most severe and clinically urgent end of nephritic spectrum
Primary Nephritic Syndromes
Post-infectious, IgA nephropathy, Henoch-Schonlein purpora, Pauci-immune glomerulonephritis, anti-glomerular basement membrane glomerulonephritis (Goodpastures)
Post Infectious Glomerulonephritis
1-3 weeks after Group A strepinfection (pharyngitis or impetigo)
Good prognosis in kids, but adults prone to CKD
Post Infectious GN Presentation
Pt is oliguric, edematous, hypertensive, coca-cola urine w/ RBC casts, high ASO titers
Post Infectious GN Treatment
Anti-hypertensives (ACE, ARB), salt restriction, diuretics (loops and thiazides)
IgA Nephropathy
AKA Bergers Disease, most common primary GN worldwide
IgA deposition in glomerular mesangium leading to an inflammatory response
Most common in kids/young adults
IgA Nephropathy Presentation
Coca-cola urine 1-3 days after URI or GI infection
Hematuria, proteinuria, increased IgA levels, normal complement
IgA Nephropathy Treatment
Corticosteroids if proteinuria is1-3.5g/day
ACE, ARB if proteinuria, want BP <130/80
Henoch-Schonlein Purpura
Systemic small vessel vasculitis associated w/ IgA deposition in vessel walls
Most common in kids, associated with infection
Henoch-Schonlein Presentation
Palpable purpura in legs and butt w/ arthralgia and abdominal symptoms
Decreased GFR
No definitive treatment but can try plasmapheresis and DMARDs
DMARDs
Disease modifying antirheumatic drugs-azathioprine, cyclophosphamide, hydroxychloroquine, methotrexate
Pauci-immune Glomerulonephritis (ANCA-associated)
Seen with small vessel vasculitis (granulomatosis with polyangitis, eosinophilic granulomatosis w/ polyangitis, microscopic polyangitis
ANCA Asscoiated GN Presentation
Fever, malaise, weight loss, purport
90% have respiratory symptoms with nodular lesions that can bleed
Labs are ANCA positive, slight hematuria and proteinuria
ANCA Associated GN Treatment
High dose corticosteroids, DMARDs
75% remission with treatment
Anti-glomerular Basement Membrane Glomerulonephritis (Goodpastures)
GN + pulmonary hemorrhage
Basement membrane injury from anti-GBM antibodies
Accounts for 10-20% of patients with RPGN
Peak in 2-3rd decades and 6-7th decades
Goodpastures Presentation
Typically have lung injury
20-60% preceded by URO; hemoptysis, dyspnea, RPGN
Labs have anti-GBM antibodies, proteinuria, sputum shows hemosiderin-laden macrophages
Pulmonary infiltrates on CXR
Goodpastures Treatment
Plasmapheresis to remove antibodies
Corticosteroids and DMARDs to prevent new antibodies/inflammatory response
Nephrotic Syndrome Labs
Urine protein excretion >3.5g, hypoalbuminemia (<3g/dL), oval fat bodies in urinary sediment (from hyperlipidemia), deficient vitamin D, zinc and copper levels
Nephrotic Syndrome Presentation
Peripheral edema is hallmark (when serum albumin <2g), dyspnea, hyperlipidemia,
Nephrotic Syndrome
Significantly increased basement membrane permeability
Nephrotic Syndrome Treatment
Increased protein intake, salt restriction, thiazide and loop diuretics, high intensity statins, anticoags
Types of Nephrotic Syndromes
Minimal Change Disease, membranous nephropathy, focal segmentation glomeruulosclerosis (FSGS)
Minimal Change Disease
Increased glomerular permeability, foot process effacement
Mostly seen in kids (80% of all proteinuria)
men=women but boys>girls
Membranous Nephropathy
Most common primary nephrotic syndrome in adults
Immune complex deposition in glomerular capillary walls result in increased permeability
Membranous Nephropathy Presentation
Asymptomatic; edema w/ frothy urine, high incidence of venous thromboembolism
Subnephrotic syndrome-classic nephrotic syndrome
Membranous Nephropathy Treatment
ACE/ARB if BP >125/75
Corticosteroids in patients with no improvements after 6 months of conservative care
Focal Segmental Glomerulosclerosis (FSGS)
Increased permeability due to podocyte injury
FSGS Presentation
Proteinuria is initial presenttion
FSGS Treatment
Diuretics for edema, ACE/ARB to reduce proteinuria/HTN, Statins for hyperlipidemia, high dose corticosteroids for overt nephrotic syndrome for 16 weeks
Simple Renal Cyst Epidemiology
65-70% of renal masses, mostly >70
Most common incidental finding with little clinical significance
Simple Renal Cyst
Develop in cortex and medulla with solitary or multiple, unilateral/bilateral, <1 cm or >10cm, clear to straw-colored fluid filled, round or oval, with a single epithelial layer lining
Simple Renal Cyst Presentation
No clinical manifestations
Rupture rares>flank pain, hematuria
Infection rare>insidious fever, vague limbo-abdominal pain, +/-hematuria or pyuria
HTN rare due to. compression of renal parenchyma
Simple Renal Cyst Diagnositics
Ultrasound-sharply demarcated with smooth thin walls, anechoic, enhanced back wall
Complex Cyst Diagnostics
Ultrasound-thick walls/septations, calcifications, solid components, mixed echogenicity, vascularity
CT w/ and w/out contrast
Acquired Renal Cysts
Most common reason is chronic renal failure
dialysis increases risk of development (yearly screening every 3-5 years after dialysis)
Rarely symptomatic, small-normal kidneys, may increase risk of RCC
Diagnostics of Acquired Renal Cysts
Ultrasound: Bilateral involvement, >4 cysts, diameter <0.5cm up to 2-3cm
Cyst Treatment
Excision based on Bosniak classification Pain: acetaminophen or NSAIDs if normal kidney function Persistent pain (cysts >5cm): percutaneous aspiration w/ injection of sclerosing agent, laparoscopic unroofing
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Aggressive form (more common) is PKD1, slow growth is PKD2, 5% spontaneous Irreversible decline in renal function by age 60 (50%)
ADPKD Pathology
Multiple cysts with bilateral involvement, gradual cyst growth, gradual loss of parenchyma, significant kidney enlargement, progressive decline in renal function (GFR)
ADPKD Clinical Presentation
Presents in 30s-40s with pain (abdominal, flank, back, chest), 50% have HTN, large palpable kidneys, frequent UTIs (treat with cipro), hematuria, mild proteinuria
ADPKD Diagnostics
Ultrasound for screen/monitoring
CBC (anemia), CMP(decline kidney function), UA (blood, protein), genetic screening (PKD 1/2)
ADPKD Treatment
ACE/ARB, low sodium/caffeine, pain management, avoid nephrotoxic agents/contact sports, manage complications (infection, hemorrhage, etc)
Dialysis or transplant in end stage
Medullary Sponge Kidney
Congenital disorder, mostly sporadic and asymptomatic
Characterized by dilation of collecting tubules (1+ renal papillae in 1 or both kidneys) and medullary cysts of variable sizes
Complications of Medullary Sponge Kidney
Nephrolithiasis, UTI, hematuria, decreased urinary concentration, renal insufficiency (rare)
Medullary Sponge Kidney Diagnosis
not until 4-5th decade
Intravenous pyelography (IVP) with “brush” or linear striations radiating outward from calyces
Multidetector-row CT (IVP like image with “brush”)
Medullary Sponge Kidney Treatment
No known therapy
Good hydration, thiazide diuretic for hypercalciuria, antibiotics for UTI
Maintain renal function to avoid decline
Medullary Cystic Disease (Nephronophthisis)
Autosomal recessive inheritance
Characterized by reduced urinary concentration (bland urinary sediment, polyuria, polydipsia) and chronic tubulointerstitial nephritis w/ renal cysts
Medullary Cystic Disease Diagnostic
Clinical characteristics, retinitis pigmentosa
Confirmed with genetic testing, ultrasound (normal-small kidney w/ increased echogenicity w/ loss of corticomedullary differentiation)
Medullary Cystic Disease Treatment
Supportive care, will end up on dialysis or kidney transplant
Renal Cell Carcinoma
Most common primary renal malignancy; 6-8th decade most common
SMOKING is huge risk factor, most are sporadic
RCC Pathology
75-85% clear cell-deletion of chromosome 3p, usually a solid mass in the proximal tubule
10-15% papillary-proximal tubule; stage 1 has good prognosis and stage 2 is aggressive
RCC Presentation
Triad (but not usually together): Hematuria, abdominal mass, flank pain
left-sided scrotal varicocele, weight loss, metastasis to lungs, brain, bone, liver and lymph nodes; paraneoplastic syndromes
RCC Diagnostics
Abdominal CT with and without contrast, MRI is second line (if CT/US non-diagnostic) tissue biopsy (through full or partial nephrectomy) for solid renal mass
RCC Treatment
Surgery is curative for stages 1-3
Stage 4 becomes metastatic; can do surgery, radiation, systemic therapy-dependent on prognosis
Small Renal Mass
<4cm with enhancement on contrast imaging, solid or complex cystic
Male is more likely to be malignant
<2cm has 20-40% chance of benign
>4cm 20-30% chance of RCC (malignant)
Small Renal Mass Management
Surgery (partial nephrectomy), thermal ablation if <3cm, surveillance if <2cm
Wilms Tumor
Most common (95%) primary renal malignancy in kids, usually sporadic
Wilms Tumor Pathology
Usually a solitary lesion composed of blastemal, stroll and epithelial cells surrounded by a pseudo capsule
Due to abnormal renal development leading to proliferation of cells
Wilms Tumor Presentation
Abdominal mass (usually aymptomatic) Can have: abdominal pain, hematuria, fever, hypertension
Wilms Tumor Diagnostics
Histologic confirmation through excision or biopsy
Initial study is ultrasound (CT or MRI if not enough info); Labs: coag studies, CBC, Ca, liver function, UA, renal function
ALWAYS evaluate other kidney for comparison!
Wilms Tumor Treatment
Chemo and surgical excision
Refer to ped cancer center
Chest imaging for mets
Renovascular Disease
80-90% atherosclerotic
10-15% fibromuscular dysplasia
associated with accelerated target organ injury (LVH, renal fibrosis)
Renovascular Disease Presentation
Young onset/severe/resistant HTN, acute rise in normally stable BP
Serum creatinine raise >30% after ACE/ARB, abdominal bruit
Renovascular Disease Diagnostics
CTA most common, Renal arteriography is gold standard
Labs: elevated BUN and creatinine
Only test if intervention will be started
Atherosclerotic Renal Artery Stenosis
AKA Ischemic nephropathy; usually >45years
reduced blood flow to kidney, involving aortic orifice or proximal main renal artery
Atherosclerotic Renal Artery Stenosis Diagnosis
Luminal occlusion of at least 60-75%
Atherosclerotic Renal Artery Stenosis Treatment
Treat HTN, monitor CKD, CV prevention w/statins/aspirin; revascularization (angioplasty with or without stent/bypass)
Fibromuscular Dysplasia
Usually women <50 years
Noninflammatory, nonatherosclerotic disorder leading to arterial stenosis, occlusion, aneurysm, dissection and tortuosity leading to reduced blood flow to kidney; commonly in carotids and renal artery
Fibromuscular Dysplasia Presentation
HA, pulsatile tinnitus, neck pain, flank/abdominal pain, HTN, bruits, TIA/stroke
Classified as multifocal (string of beads) or focal (circumferential or tubular stenosis)
Fibromuscular Dysplasia Management
ACE/ARB-check serum creatinine Q6M and duplex doppler Q6-12M
OR: surgical (angioplasty-preferred treatment)
ACEs and ARBs in Kidneys
These blunt effect of auto regulation leading to reduced GFR which can possibly cause AKI
Acute kidney injury will happen within 3-4 days-check creatinine levels in 5-7 days and 1 week after to monitor!
What renovascular disease patient should get surgical treatment?
Short duration of ^ BP, failure/intolerance of medication therapy, recurrent flash pulmonary edema/refractory heart failure
Renal Ultrasonography
Choice test for obstructive disease, most commonly used initial test
Less sensitive for masses, can use doppler for vascular flow assessment
CT Scan
Gold standard for renal stones
Complementary to ultrasound, do WITHOUT contrast
loaves obstruction, evaluate tumors, diagnose RVT, high sensitivity for PKD
Radionuclide Scan
Preferred test in children bc it has less radiation than CT
Finds obstructions, determines function of each kidney
MRI
Gold standard for renal vein thrombosis (with renal venography and CT)
Further valor masses
Caution with gadolinium with GFR <30-can lead to nephrogenic system fibrosis
Nephrogenic System Fibrosis
Fibrosis of skin, muscle, fascia, lungs and heart>wheelchair bound within weeks, only happens in those with renal failure w/ gad use
Renal Arteriography and Venography
Preferred test for polyarteritis nodes, can also identify arterial and venous occlusions
Used less than CT/MRI bc its more invasive
Intravenous Pyelogram (IVP)
AKA IV urogram
Assess caliceal anatomy, size and shape of kidney
Highsensitivity and specificity for stones
LOTS OF RADIATION and contrast use>infrequently used
Renal Biopsy
Indicated for nephritic and nephrotic syndromes and unexplained AKI
Can do open renal, trans jugular renal or percutaneous (uses US and local anesthesia) renal biopsy
Hydronephrosis
Unilateral or bilateral edema of collecting system-fluid around kidneys
Almost always asymptomatic, but possible pain if obstructed
Hydronephrosis Diagnosis and Treatment
Ultrasound finds obstruction, CT if US is not diagnostic (non obstructive-can lead to diabetes insipidus)
Relieved by stent
Acute Kidney Injury
Precipitous and significant decrease in GFR (>50%) over a period of hours-days (but <3 months) with accompanying accumulation of nitrogenous waste in the body and inability to maintain fluid and electrolyte balance
KDIGO (kidney disease: improving global outcomes) Classification
Increase in serum creation by >0.3mg/dL within 48 hoursOR ^ in serum creatinine to >1.5x baseline within last 7 days OR urine volume <0.5mL/kg/hour for 6 hours